Keane Group, Inc. (NYSE:FRAC)
Keane Group, Inc. (NYSE:FRAC) represented a move of -0.27 percent or $-0.09 per share and closed its previous day trading session at $11.12. 808356 Shares were traded in the last trading session with an Average Volume of 1.15 Million Shares. The stock currently has a Market Capitalization of 1.18 Billion.
Keane Group, Inc. is a provider of integrated well completion services primarily in the U.S. It focuses on complex, technically demanding completion solutions. The company primary service offerings include horizontal and vertical fracturing, wireline perforation and logging and engineered solutions as well as other value-added service offerings. Keane Group, Inc. is headquartered in Houston, Texas.
The stock traded between $10.12 and $19.83 over 1-Year time period showing its price to sales ratio of 0.55. Keane Group, Inc. (NYSE:FRAC) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-9.23 and 200-Day Simple Moving Average of $-19.54. Its Price to Free Cash Flow is 3.63 and Price to Book of 2.36.
Analyst’s recommended the stock as 1.8 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Keane Group, Inc. (NYSE:FRAC) reported its Actual EPS of $0.22/share. The analysts offering Earnings Estimates for the company were believing that Keane Group, Inc. could bring EPS of $0.22/share. The difference between Actual EPS and Estimated EPS was 0 Percent. Thus showing an Earnings Surprise of 0 Percent.
Integra LifeSciences Holdings Corporation (NASDAQ:IART)
In the last trading session, Integra LifeSciences Holdings Corporation (NASDAQ:IART) added its value by 0.68% closing at the price of $53.63. The stock currently has market capitalization of 4.54 Billion, with average volume of 619.82 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Integra LifeSciences Holdings Corporation (NASDAQ:IART) is showing beta of 0.76. This particular value of beta suggests that Integra LifeSciences Holdings Corporation (NASDAQ:IART) has historically moved 76% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Integra LifeSciences Holdings Corporation (NASDAQ:IART) is at $1.53.
The stock currently has RSI of 41.98. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive and general surgery. Integra’s orthopedic products include devices and implants for foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. Surgeons don’t have a minute to waste. They navigate a world of uncertainty while making thousands of decisions every day. These decisions directly affect patients – and surgeons.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) topped its 52-week high price of $67.50 on 06/18/18 and 52-Week Low Price of $45.96 on 01/02/18. The Stock currently has P/E (price to earnings ttm) of 35.03 and Weekly volatility of 2.59% and monthly volatility of 3.12% respectively.